Opsiria (sirolimus)
- Region
- 🇪🇺 EU
- Active substance
- sirolimus
- Company
- Santen Oy
- Status
- Application withdrawn
- Therapeutic area
- Uveitis
- Application
- EMEA/H/C/003978
- ATC
- S01XA23
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Hyftor Authorised · Plusultra pharma GmbH
- 🇪🇺 Rapamune Authorised · Pfizer Europe MA EEIG
- 🇪🇺 Torisel Authorised · Pfizer Europe MA EEIG
Follow Opsiria
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.